4.5 Article

A prospective observational study of the prevalence and risk factors for colonization by antibiotic resistant bacteria in patients at admission to hospital in Singapore

Journal

BMC INFECTIOUS DISEASES
Volume 14, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1471-2334-14-298

Keywords

Antibiotics; Colonization; ESBL; Fecal carriage; MRSA

Funding

  1. Health Quality Improvement Fund grant from the Ministry of Health, Singapore
  2. National Healthcare Group Clinician Scientist Career Scheme

Ask authors/readers for more resources

Background: Drug resistant organisms pose an increasing threat to the successful treatment of common infections. Understanding colonization patterns of these bacteria is important for effective antibiotic treatment and infection control guidelines. Methods: A prospective observational study was performed to determine the prevalence of colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococcus (VRE) among patients admitted via the emergency department to a public tertiary hospital in Singapore. Anterior nares, groin, axillary and rectal swabs were collected at admission and cultured using standard bacteriological techniques. Clinical data including healthcare contact within the past 12 months and recent antibiotic use was collected and analyzed using a logistic regression model. Results: 1006 patients were screened. 124 (12.4%) were colonized by ESBL-E, 18 (1.8%) by MRSA while no VRE was detected. Antibiotic use within the past month was the only significant predictor for ESBL-E colonization in the regression model, with an adjusted odds ratio (AOR) of 2.58 (1.04 to 6.42). In participants recently prescribed antibiotics and hospitalized in the previous 3 months, 29.4% were colonized by ESBL-E. This represented 20.2% of the total ESBL-E burden, and ESBL-E was also detected in 6.3% of participants with no healthcare contact. Hospitalization and outpatient hospital visits predicted MRSA colonization in the univariate analysis. Neither was statistically significant in the logistic regression model, with AORs for MRSA colonization following hospitalization in the past 3 and 12 months of 3.81 [95% CI 0.84-17.28] and 3.48 [0.64-18.92] respectively. Conclusion: A high prevalence of colonization with ESBL-E was evident among patients at admission, even in the absence of recent antibiotic use or contact with healthcare.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study

Po Ying Chia, Sean Wei Xiang Ong, Calvin J. Chiew, Li Wei Ang, Jean-Marc Chavatte, Tze-Minn Mak, Lin Cui, Shirin Kalimuddin, Wan Ni Chia, Chee Wah Tan, Louis Yi Ann Chai, Seow Yen Tan, Shuwei Zheng, Raymond Tzer Pin Lin, Linfa Wang, Yee-Sin Leo, Vernon J. Lee, David Chien Lye, Barnaby Edward Young

Summary: This study found that mRNA vaccines are highly effective at preventing symptomatic and severe COVID-19 associated with B.1.617.2 infection. Vaccination is associated with a faster decline in viral RNA load and a robust serological response.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Immunology

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, Yun Shan Goh, Siti Naqiah Amrun, Nicholas Ang, Menaka Priyadharsani Rajapakse, Josephine Lum, Shihui Foo, Cheryl Yi-Pin Lee, Guillaume Carissimo, Rhonda Sin-Ling Chee, Anthony Torres-Ruesta, Matthew Zirui Tay, Zi Wei Chang, Chek Meng Poh, Barnaby Edward Young, Paul A. Tambyah, Shirin Kalimuddin, Yee-Sin Leo, David C. Lye, Bernett Lee, Subhra Biswas, Shanshan Wu Howland, Laurent Renia, Lisa F. P. Ng

Summary: This study reveals that patients infected with the Delta 382 SARS-CoV-2 variant have an enhanced adaptive immune response, characterized by an enrichment of genes related to T cell functionality, a more robust SARS-CoV-2-specific T cell immunity, and a quicker antibody response.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial

I. Russel Lee, Steven Y. C. Tong, Joshua S. Davis, David L. Paterson, Sharifah F. Syed-Omar, Kwong Ran Peck, Doo Ryeon Chung, Graham S. Cooke, Eshele Anak Libau, Siti-Nabilah B. A. Rahman, Mihir P. Gandhi, Luming Shi, Shuwei Zheng, Jenna Chaung, Seow Yen Tan, Shirin Kalimuddin, Sophia Archuleta, David C. Lye

Summary: This study aims to evaluate the clinical efficacy and economic impact of early stepdown to oral antibiotics in the treatment of Gram-negative bacteraemia. It is an international randomized controlled trial, with the primary outcome being 30-day all-cause mortality.

TRIALS (2022)

Letter Allergy

In vitro vaccine challenge of PBMCs from BNT162b2 anaphylaxis patients reveals HSP90α-NOD2-NLRP3 nexus

Hui Ling Ko, Nicole Zhuo, Zi Wei Chang, Anindita Santosa, Shirin Kalimuddin, Xin Rong Lim, Seow Yen Tan, David Chien Lye, Dorothy Toh, Barnaby Edward Young, Laurent Renia, Haur Yueh Lee, Ee Chee Ren

ALLERGY (2023)

Article Infectious Diseases

Vaccine effectiveness against Delta, Omicron BA.1, and BA.2 in a highly vaccinated Asian setting: a test-negative design study

Celine Y. Tan, Calvin J. Chiew, Deanette Pang, Vernon J. Lee, Benjamin Ong, David Chien Lye, Kelvin Bryan Tan

Summary: This study compared the vaccine effectiveness of the primary series and booster against Delta, Omicron BA.1, and BA.2 variants in Singapore. The primary series provided greater protection against Delta infection (45%) compared to Omicron infection (21% for BA.1, 18% for BA.2) within 2 months of vaccination. The booster had similar effectiveness against BA.1 and BA.2 infection (44% and 40% respectively) and provided comparable protection against severe disease as the primary series for Delta (80% for both variants).

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Virology

Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters

Angeline Rouers, Nathan Wong, Yun Shan Goh, Anthony Torres-Ruesta, Matthew Zirui Tay, Zi Wei Chang, Siew-Wai Fong, Vanessa Neo, Isaac Kai Jie Kam, Nicholas Kim-Wah Yeo, Yuling Huang, Chiew Yee Loh, Pei Xiang Hor, Joel Xu En Wong, Yong Jie Tan, Paul A. Macary, Xinlei Qian, Wang Bei, Eve Zi Xian Ngoh, Siti Nazihah Mohd Salleh, Cheng- Wang, Xuan Ying Poh, Suma Rao, Po Ying Chia, Sean W. X. Ong, Tau Hong Lee, Ray J. H. Lin, Clarissa Lim, Jefanie Teo, Ee Chee Ren, David Chien Lye, Barnaby E. Young, Lisa F. P. Ng, Laurent Renia

Summary: The waning antibody levels against SARS-CoV-2 and the emergence of variants of concern call for booster vaccinations, especially for the elderly population. In this study, the responses to homologous and heterologous mRNA booster vaccines were analyzed. It was found that elderly individuals who received the heterologous vaccine regimen displayed higher levels of neutralizing antibodies and increased immunoglobulin G memory B cells, particularly against the Omicron variant. The T cell responses were also increased in elderly individuals given the heterologous regimen.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Infectious Diseases

Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12-17years in Singapore: a national cohort study

Calvin J. Chiew, M. Premikha, Chia Yin Chong, Wycliffe E. Wei, Benjamin Ong, David Chien Lye, Derrick Heng, Vernon J. Lee, Kelvin Bryan Tan

Summary: In Singapore, the effectiveness of the Pfizer-BioNTech vaccine was studied in adolescents aged 12-17. Two doses of the vaccine were found to be effective in preventing infection from the delta and omicron variants, with effectiveness rates of 66% and 25% respectively. The vaccine also showed high effectiveness in preventing hospitalization due to these variants, with rates of 83% and 75%. Additionally, a third booster dose further increased protection against the omicron variant.

LANCET INFECTIOUS DISEASES (2023)

Review Virology

Clinical trials on the pharmacological treatment of long COVID: A systematic review

Ying Jie Chee, Bingwen Eugene Fan, Barnaby Edward Young, Rinkoo Dalan, David C. C. Lye

Summary: Post-acute sequelae of SARS-CoV-2 infection, also known as long COVID, is an emerging public health concern. This review summarizes published trials and ongoing research on managing long COVID, highlighting the need for standardized diagnostic criteria and outcome measures. Current trials focus on individual symptoms and organ dysfunction, and more research is needed to address the unmet needs of patients.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Virology

Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection

Siew-Wai Fong, Yun Shan Goh, Anthony Torres-Ruesta, Zi Wei Chang, Yi-Hao Chan, Vanessa Kexin Neo, Bernett Lee, Kaibo Duan, Siti Naqiah Amrun, Nicholas Kim-Wah Yeo, Hsiuyi Chen, Matthew Zirui C. Tay, Guillaume Carissimo, Seow Yen Tan, Yee-Sin Leo, David Lye, Laurent Renia, Barnaby Edward Young, Lisa F. P. Ng

Summary: Long-term complications from COVID-19 are concerning, but it is unclear if they are due to prolonged inflammation. Vaccination may reduce these complications. A study on hospitalized patients over 24 months found that post-COVID-19 symptoms persisted for 2 years, but prolonged inflammation resolved after 2 years. Biomarkers associated with persistent inflammation and symptoms were identified, which could help identify high-risk survivors.

JOURNAL OF MEDICAL VIROLOGY (2023)

Letter Hematology

Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients

Samuel Sherng Young Wang, Keefe Chee, Shiun Woei Wong, Guat Bee Tan, Hong Ang, Bernard PuiLam Leung, Chuen Wen Tan, Kollengode Ramanathan, Rinkoo Dalan, Christine Cheung, David Chien Lye, Barnaby Edward Young, Eng Soo Yap, Yew Woon Chia, Bingwen Eugene Fan

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Article Immunology

Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections

Daniel A. Sweeney, Bonifride Tuyishimire, Neera Ahuja, John H. Beigel, Tatiana Beresnev, Valeria D. Cantos, Jose G. Castro, Stuart H. Cohen, Kaitlyn Cross, Lori E. Dodd, Nathan Erdmann, Monica Fung, Varduhi Ghazaryan, Sarah L. George, Kevin A. Grimes, Noreen A. Hynes, Kathleen G. Julian, Sheetal Kandiah, Hannah Jang Kim, Corri B. Levine, David A. Lindholm, David C. Lye, Ryan C. Maves, Myoung-don Oh, Catharine Paules, Rekha R. Rapaka, Willam R. Short, Kay M. Tomashek, Cameron R. Wolfe, Andre C. Kalil

Summary: We conducted a secondary analysis of the ACTT-2 randomized controlled trial sponsored by the National Institutes of Health and found that baricitinib reduced the risk of secondary infections by 50% after adjusting for baseline and postrandomization patient characteristics. This discovery provides a novel mechanism for the benefits of baricitinib and supports its safety as an immunomodulator for the treatment of COVID-19.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Microbiology

Clinical Predictors for Abnormal ALT in Patients Infected with COVID-19-A Retrospective Single Centre Study

Wei Da Chew, Jonathan Kuang, Huiyu Lin, Li Wei Ang, Wei Lyn Yang, David C. Lye, Barnaby E. Young

Summary: This retrospective observational study aimed to identify simple clinical predictors for abnormal alanine aminotransferase (ALT) in COVID-19 infections. The study found that older age, hyperlipidemia, and hypertension were independent risk factors for abnormal ALT. Additionally, an R-factor>=1 on admission and hypoxia were also associated with abnormal ALT. Patients with abnormal ALT had a more severe course of illness, requiring supplementary oxygen, ICU/HDU admission, and intubation at higher rates. However, there was no difference in the death rate between the two groups.

PATHOGENS (2023)

Letter Health Care Sciences & Services

Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant

Matthew Zirui Tay, Yun Shan Goh, Siew-Wai Fong, Zi Wei Chang, Angeline Rouers, Nathan Wong, Anthony Torres-Ruesta, Yuling Huang, Sooriya Kannan Selvam, Pei Xiang Hor, Chiew Yee Loh, Bei Wang, Siti Nazihah Mohd Salleh, Eve Zi Xian Ngoh, Raphael Tze Chuen Lee, Vanessa Neo, Isaac Kai Jie Kam, Xuan Ying Poh, Suma Rao, Po Ying Chia, Sean W. X. Ong, Tau Hong Lee, Clarissa Lim, Jefanie Teo, Sebastian NCID Study Grp, Cheng-I PRIBIVAC Cohort Study Grp, Sebastian Maurer-Stroh, Cheng- Wang, Yee-Sin Leo, Raymond Tzer Pin Lin, David C. Lye, Barnaby Edward Young, Lisa F. P. Ng, Laurent Renia

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2023)

Article Pediatrics

BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study

Chee Fu Yung, Deanette Pang, Kai Qian Kam, David C. Lye, Benjamin Ong, Chia Yin Chong, Kelvin B. Tan

Summary: This study aimed to investigate the level of protection provided by the BNT162b2 COVID-19 vaccine against Omicron variant infection in children and the impact of previous variant-specific infection on vaccine effectiveness. The study found that the vaccine provided 74-85.7% protection against BA.4 or BA.5 infection and 47.9-62.8% protection against XBB infection. The sequence of previous infection had an influence on vaccine effectiveness.

LANCET CHILD & ADOLESCENT HEALTH (2023)

Article Medicine, Research & Experimental

Myeloperoxidase inhibition may protect against endothelial glycocalyx shedding induced by COVID-19 plasma

Andrew Teo, Louisa L. Y. Chan, Christine Cheung, Po Ying Chia, Sean Wei Xiang Ong, Siew Wai Fong, Lisa F. P. Ng, Laurent Renia, David Chien Lye, Barnaby Edward Young, Tsin Wen Yeo

Summary: Teo et al. study found that neutrophil activity and endothelial glycocalyx damage increase with disease severity in COVID-19 patients, and persist despite clinical recovery.

COMMUNICATIONS MEDICINE (2023)

No Data Available